Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glucose circadian rhythm disruption is associated with preeclampsia.

Chronobiology international·2026
Same author

A risk-based model for unplanned cesarean delivery following induction of labor in term hypertensive nulliparas.

Archives of gynecology and obstetrics·2026
Same author

Efficacy, Safety and Tolerability of Volixibat, an IBAT Inhibitor, in Patients With Intrahepatic Cholestasis of Pregnancy.

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Factors associated with enrollment in a randomized clinical trial of docosahexaenoic supplementation in toddlers born preterm.

Clinical trials (London, England)·2025
Same author

Timing of Delivery in Preeclampsia: Time to Reconsider?

BJOG : an international journal of obstetrics and gynaecology·2025
Same author

Pulse Pressure and Adverse Maternal and Perinatal Outcomes in Patients With Mild Chronic Hypertension During Pregnancy.

O&G open·2025
Same journal

The economic burden of preeclampsia: a systematic review.

Hypertension in pregnancy·2026
Same journal

Maternal hypertensive disorders in East Asia, 1990-2023: incidence, deaths, DALYs and maternal mortality in women aged 20-54 years using GBD 2023.

Hypertension in pregnancy·2026
Same journal

Identification risk factors for perinatal complications among pregnant women with pulmonary arterial hypertension.

Hypertension in pregnancy·2026
Same journal

Placental CD4⁺ T cells from women with gestational diabetes recapitulate disease features in a pregnant rat model, improved by metformin or mitotempo.

Hypertension in pregnancy·2026
Same journal

Bioelectrical impedance-derived extracellular fluid expansion and perinatal outcomes in preeclampsia.

Hypertension in pregnancy·2026
Same journal

Endoplasmic reticulum stress-related genes drive M1 macrophage polarization in preeclampsia via modulating metabolic reprogramming: a bioinformatic study.

Hypertension in pregnancy·2026
See all related articles

Related Experiment Video

Updated: Jun 10, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

Does C-reactive protein predict recurrent preeclampsia?

Hilary S Gammill1, Robert W Powers, Rebecca G Clifton

  • 1Department of Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh, PA, USA. hgammill@u.washington.edu

Hypertension in Pregnancy
|August 13, 2010
PubMed
Summary
This summary is machine-generated.

This study found that C-reactive protein (CRP) levels, whether at baseline or changing during pregnancy, were not associated with recurrent preeclampsia in women with a history of the condition. These findings suggest CRP may not be a reliable predictor for preeclampsia recurrence.

More Related Videos

A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function
10:44

A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function

Published on: June 2, 2019

Related Experiment Videos

Last Updated: Jun 10, 2026

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
05:31

Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas

Published on: January 26, 2024

A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function
10:44

A Plate-based Cytotoxicity Assay for the Assessment of Rat Placental Natural Killer Cell Cytolytic Function

Published on: June 2, 2019

Area of Science:

  • Obstetrics and Gynecology
  • Inflammation Research
  • Maternal-Fetal Medicine

Background:

  • Preeclampsia is a serious pregnancy complication.
  • Recurrent preeclampsia poses significant risks to maternal and fetal health.
  • Identifying reliable biomarkers for preeclampsia recurrence is crucial for improved management.

Purpose of the Study:

  • To investigate the association between C-reactive protein (CRP) levels and the recurrence of preeclampsia.
  • To determine if baseline CRP concentration or changes in CRP over gestation predict preeclampsia recurrence.

Main Methods:

  • Longitudinal serum samples were collected from women with a history of preeclampsia.
  • C-reactive protein (CRP) levels were measured in these samples.
  • Statistical analyses were performed to assess the association between CRP and preeclampsia recurrence, adjusting for confounders.

Main Results:

  • A total of 255 women were studied, with 50 experiencing preeclampsia recurrence.
  • Baseline CRP concentrations did not differ significantly between women who did and did not experience recurrence.
  • Neither elevated baseline CRP nor its change throughout gestation was significantly associated with recurrent preeclampsia.

Conclusions:

  • In women with prior preeclampsia, baseline CRP levels are not predictive of recurrence.
  • Changes in CRP concentration during pregnancy do not appear to be associated with recurrent preeclampsia.
  • These findings indicate that CRP may not serve as a biomarker for predicting preeclampsia recurrence in this population.